• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文会议>WateReuse Symposium >PREDICTING REMOVAL EFFICIENCY OF REVERSE OSMOSIS WITH RESPECT TO ENDOCRINE DISRUPTING COMPOUNDS AND PHARMACEUTICALS AND PERSONAL CARE PRODUCTS
【24h】

PREDICTING REMOVAL EFFICIENCY OF REVERSE OSMOSIS WITH RESPECT TO ENDOCRINE DISRUPTING COMPOUNDS AND PHARMACEUTICALS AND PERSONAL CARE PRODUCTS

机译：预测内分泌破坏化合物和药物和个人护理产品的反渗透去除效率

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Emerging substances of concern have gained a wide range of attention among the public with the release of several papers reporting atypical concentrations in surface waters and influent plants. In addition, the decreasing resources of potable water, lack of regulation and uncertainties of the dose-level response in humans for many of these microconstituents, does nothing but alert authorities of the imminent need to upgrade existing water treatment technology. In this effort, several pilot programs have been performed throughout the nation (and throughout the world) to identify the best treatment technology available. Historically, reverse osmosis membranes were thought to remove all molecules having a molecular weight greater than 150 (Schweitzer, 1998). However, data from pilot studies performed in Miami-Dade County, City of Sunrise, Orange County, CA, Town of Davie, and the City of Pembroke Pines revealed that though RO treatment efficiently reduces nutrients and inorganics, it is not a one-time solution for all ESOCs. Rather, a treatment train composed of reverse osmosis with UV in conjunction with an advanced oxidation process using H_2O_2 proved to be effective to remove all microconstituents at or below laboratory MDLs levels.
机译：令人担忧的新兴物质在公众中获得了广泛的关注，释放了几篇关于地表水域和流水植物的非典型浓度。此外，饮用水的资源降低，对于许多这些微耦合器的人类剂量水平反应的资源，除了提高现有水处理技术的目的需要提高现有水处理技术的情况下，没有任何内容的监管和不确定性。在这项努力中，在整个国家（和全世界）中进行了几项试点计划，以确定可用的最佳治疗技术。历史上，据认为，反渗透膜去除分子量大于150的所有分子（Schweitzer，1998）。然而，来自迈阿密戴德县的试点研究的数据，日出城市，奥兰治县，加利福镇，戴维市和彭布罗克城市透露，虽然Ro治疗有效减少营养和无机物，但这不是一次性的所有ESOCS的解决方案。相反，使用H_2O_2的使用H_2O_2结合使用uV与UV的反渗透组成的处理火车被证明是有效的，以便在实验室MDLS水平或低于实验室MDLS水平或低于实验室水平的所有微频率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号